chrX-37686032-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_021083.4(XK):c.71T>A(p.Leu24Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000405 in 1,209,275 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000070 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.000037 ( 0 hom. 17 hem. )
Consequence
XK
NM_021083.4 missense
NM_021083.4 missense
Scores
7
9
1
Clinical Significance
Conservation
PhyloP100: 7.13
Genes affected
XK (HGNC:12811): (X-linked Kx blood group antigen, Kell and VPS13A binding protein) This locus controls the synthesis of the Kell blood group 'precursor substance' (Kx). Mutations in this gene have been associated with McLeod syndrome, an X-linked, recessive disorder characterized by abnormalities in the neuromuscular and hematopoietic systems. The encoded protein has structural characteristics of prokaryotic and eukaryotic membrane transport proteins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.905
BS2
High Hemizygotes in GnomAdExome4 at 17 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XK | NM_021083.4 | c.71T>A | p.Leu24Gln | missense_variant | 1/3 | ENST00000378616.5 | NP_066569.1 | |
XK | XM_011543978.4 | c.71T>A | p.Leu24Gln | missense_variant | 1/3 | XP_011542280.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XK | ENST00000378616.5 | c.71T>A | p.Leu24Gln | missense_variant | 1/3 | 1 | NM_021083.4 | ENSP00000367879.3 | ||
ENSG00000250349 | ENST00000465127.1 | c.171+260032T>A | intron_variant | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.0000702 AC: 8AN: 113997Hom.: 0 Cov.: 24 AF XY: 0.0000277 AC XY: 1AN XY: 36123
GnomAD3 genomes
AF:
AC:
8
AN:
113997
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
36123
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000290 AC: 5AN: 172505Hom.: 0 AF XY: 0.0000326 AC XY: 2AN XY: 61397
GnomAD3 exomes
AF:
AC:
5
AN:
172505
Hom.:
AF XY:
AC XY:
2
AN XY:
61397
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000374 AC: 41AN: 1095278Hom.: 0 Cov.: 31 AF XY: 0.0000470 AC XY: 17AN XY: 361534
GnomAD4 exome
AF:
AC:
41
AN:
1095278
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
361534
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000702 AC: 8AN: 113997Hom.: 0 Cov.: 24 AF XY: 0.0000277 AC XY: 1AN XY: 36123
GnomAD4 genome
AF:
AC:
8
AN:
113997
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
36123
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 12, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals affected with XK-related conditions. This variant is present in population databases (rs371386605, gnomAD 0.007%), including at least one homozygous and/or hemizygous individual. This sequence change replaces leucine, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 24 of the XK protein (p.Leu24Gln). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at